GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
about
GABA and Glutamate Transporters in BrainMutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.A competitive inhibitor traps LeuT in an open-to-out conformation.Structures of LeuT in bicelles define conformation and substrate binding in a membrane-like contextManganese exposure inhibits the clearance of extracellular GABA and influences taurine homeostasis in the striatum of developing ratsTiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's diseaseSelected Gamma Aminobutyric Acid (GABA) Esters may Provide Analgesia for Some Central Pain ConditionsThe lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesNovel properties of a mouse gamma-aminobutyric acid transporter (GAT4).Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells.Aspects of the homeostaic plasticity of GABAA receptor-mediated inhibition.ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice.Delta-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters.Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine.Gamma-aminobutyric acid-mediated neurotransmission in the pontine reticular formation modulates hypnosis, immobility, and breathing during isoflurane anesthesia.The betaine/GABA transporter and betaine: roles in brain, kidney, and liver.GABA pharmacology: the search for analgesics.A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1)Glutamate modulation of GABA transport in retinal horizontal cells of the skate.Involvement of GABAergic and glutamatergic systems in the anticonvulsant activity of 3-alkynyl selenophene in 21 day-old rats.Pharmacological identification of a guanidine-containing β-alanine analogue with low micromolar potency and selectivity for the betaine/GABA transporter 1 (BGT1).Catalytic Enantioselective Synthesis of Guvacine Derivatives through [4 + 2] Annulations of Imines with α-Methylallenoates
P2860
Q21090476-C54713A6-AD38-4BA4-9195-1CC84A2B0FD2Q24338670-85CE106F-3CF4-4226-9379-BB4CFDCE96E7Q27653127-4FC23949-3877-4D32-9EDC-CCBDE27205F2Q27676749-40EA3566-66FA-4773-9C76-6B268014BFF5Q28384350-366D9445-1F68-4ABA-A0C0-7C679AD00A08Q33327216-9E4D8D67-DBDD-484A-B493-7F7B247B64C4Q34052708-05BA36A9-B0E7-4586-8003-97D992C0071BQ34329204-16976261-AA90-422F-BDB5-938E9D5D6297Q34437574-633D7532-FE1C-4538-8F03-A339588A1E83Q34858502-FD780854-B359-41E8-B7C5-59F2A6C06646Q35545774-6ED63680-79F1-4966-9532-4F2FFC988CBBQ35940390-2F8A8DF9-63A0-4B0A-A58F-702D6E2E90C9Q36624119-BBDB25EE-E050-4E15-A380-CE78E215DB66Q36645968-5C9F875B-322B-490A-A167-D91CFB8C00A2Q37312558-E021D2F8-FF07-4644-8209-6C9302A9034BQ37344996-6B0A5E0A-3E19-48F5-8588-883DAE25B19EQ37735049-05BF0D20-6234-4725-9DC7-6DDA4A32EA28Q38188497-AE9C90D7-0179-4446-910B-14F05F928E94Q41439937-1AFDB23D-CE27-417D-A142-DEF8A827277FQ44300275-6CBE3D12-9F90-4A28-B24F-52564A39C488Q48650701-E4A6CCEE-F637-46D6-A1F5-0967A31025C7Q48774964-107A8277-2B09-46CD-ABE0-5F4B48A1C20AQ56984785-ABDC129B-8139-4B27-B52C-30AC94729355
P2860
GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
@ast
GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
@en
type
label
GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
@ast
GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
@en
prefLabel
GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
@ast
GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
@en
P2093
P356
P1476
GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
@en
P2093
K Frydenvang
P Krogsgaard-Larsen
P304
P356
10.2174/1381612003399608
P577
2000-08-01T00:00:00Z